Key Highlights
•
Inhibition of HMGB1 restores adult hippocampal neurogenesis and spatial learning after adolescent binge alcohol exposure. This discovery offers a potential therapeutic target for reversing alcohol-induced cognitive deficits.
Source →
•
Plasma biomarkers, particularly pTau181 and the pTau181/Aβ42 ratio, show strong association with amyloid and tau PET imaging in pre-dementia stages. These findings support the use of simple blood tests to monitor Alzheimer’s disease risk in patients with mild cognitive impairment.
Source →
•
UK clinical experts have issued appropriate use recommendations for lecanemab, an anti-amyloid monoclonal antibody recently approved for Alzheimer’s disease. The guidance emphasizes safety monitoring through regular MRI scans and APOE4 genetic testing before treatment initiation.
Source →
•
This study outlines a cervical myelopathy case caused by alveolar spinal echinococcosis cysts, a rare parasitic infection. It highlights the importance of considering infectious etiologies in the differential diagnosis of spinal cord compression.
Source →
•
Dipeptidyl aminopeptidase-like protein 6 (DPP6) regulates the balance between sodium and potassium currents in heart cells, influencing cardiac electrophysiology. This discovery provides new insight into the molecular mechanisms of arrhythmogenesis and potential therapeutic targets.
Source →
Stay curious. Stay informed —
Science Briefing
